Eversept Partners’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Sell
29,343
-30,871
-51% -$3.91M 0.21% 73
2026
Q1
$6.48M Sell
60,214
-87,257
-59% -$9.82M 0.34% 56
2025
Q4
$16.7M Buy
+147,471
New +$14.1M 0.84% 32
2025
Q3
Sell
-31,496
Closed -$3.25M 90
2025
Q2
$3.25M Sell
31,496
-127,461
-80% -$12M 0.3% 44
2025
Q1
$15.6M Buy
+158,957
New +$21.2M 1.59% 23

Other funds holding GKOS

Eversept Partners's GKOS Position: Q2 2026 in Review

Eversept Partners reduced its Glaukos (GKOS) stake by 51% in Q2 2026, selling an estimated $3.91M and leaving 29,343 shares worth $4.1M. The position accounts for 0.21% of the portfolio, ranked #73.

Eversept Partners first reported a position in GKOS in Q1 2025 and has held it in 5 quarters since. The position peaked at $16.7M in Q4 2025. 366 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Eversept Partners held 29,343 shares of Glaukos worth $4.1M as of Q2 2026.
  • Eversept Partners sold 30,871 Glaukos shares in Q2 2026, an estimated $3.91M.
  • Glaukos made up 0.21% of Eversept Partners's portfolio in Q2 2026, its #73 holding.
  • Eversept Partners first reported a position in Glaukos in Q1 2025 and has held it in 5 quarters since.
  • Eversept Partners's Glaukos position peaked at $16.7M in Q4 2025.
  • 366 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.